findmyKOL
Clinical trialNCT06220188RecruitingPhase 2Interventional

PSMA-RLT in Biochemically Recurrent PCa

SponsorMedical University of ViennaEnrollment20Prostate Cancer Recurrent
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Medical University of Vienna

    Vienna, Austria

    Pawel Rajwa, MDSazan Rasul, PhD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Jan 2024
Primary completion
30 Jun 2026
Completion
31 Jan 2027
Last update posted
13 Feb 2024
Registered enrollment
20
Registry id
NCT06220188

Cross-registrations

EU-CTR / CTIS (EudraCT)2022-003713-11

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.